Less-intensive drug combination is more effective in treating acute myeloid leukemia, clinical trial finds
Investigators from the Mass General Brigham Cancer Institute have found that adults with newly diagnosed acute myeloid leukemia (AML) receiving a less-intensive combination of azacitidine and venetoclax had more than twice ...
8 hours ago
0
3







